Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib

키워드

참고문헌 (5)

1. Cersosimo RJ, "Gefitinib: an adverse effects profile", Expert Opin Drug Saf, 5, pp.469~479 (2006)[DOI]
2. Yan X, "Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases", Cancer, 115, pp.5018~5025 (2009)[DOI]
3. Kousha M, "Pulmonary aspergillosis: a clinical review", Eur Respir Rev, 20, pp.156~174 (2011)[DOI]
4. Cornillet A, "Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey", Clin Infect Dis, 43, pp.577~584 (2006)[DOI]
5. Brooks MB, "Erlotinib and gefitinib, epidermal growth factor receptor kinase inhibitors, may treat non-cancer-related tumor necrosis factor-<TEX>$\alpha$<", TEX> mediated inflammatory diseases, 2013, pp.18, e3~e5